Patusky Christopher's Form 4 filing
United Therapeutics Corp (UTHR) · filed Sep 5, 2024
- Accession no.
- 0001415889-24-022908
- Filed
- Sep 5, 2024
- Trade date
- Sep 3-4, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.77M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patusky ChristopherCIK 0001231427 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Common Stock | MOption exerciseAcquired | +700 | $175.43 | +$122,801 | 1,600 | Direct | |
| Sep 3, 2024 | Common Stock | SSaleDisposed | −700 | $360.31F1 | −$252,217 | 900 | Direct | |
| Sep 4, 2024 | Common Stock | MOption exerciseAcquired | +4,300 | $175.43 | +$754,349 | 5,200 | Direct | |
| Sep 4, 2024 | Common Stock | SSaleDisposed | −4,300 | $353.36 | −$1,519,448 | 900 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Common Stock | MOption exerciseDisposed | −700 | $0.00 | $0 | 14,300 | Direct | |
| Sep 4, 2024 | Common Stock | MOption exerciseDisposed | −4,300 | $0.00 | $0 | 10,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $360.17 to $360.635. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.